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Summary 
‘Low risk’ populations typically receive less intervention from health insurance providers’                       
preventative programs. However, focusing on ‘high risk’ populations misses early stage                     
chronic disease, which offers some of the most compelling opportunities for                     
cost-effective interventions that improve health outcomes. Digital care management                 
programs can reduce healthcare costs, improve the quality of care and be implemented on                           
a scale that covers the spectrum of patient risk. However, it is not clear how to target                                 
patients who are most likely to benefit from these programs ex-ante, a further shortcoming                           
of current ‘risk score’ based approaches.This study focuses on defining impactability (as a                         
dollar value), by identifying those patients most likely to benefit from technology enabled                         
care management, delivered through a digital health platform, including a mobile app and                         
clinician web dashboard. Anonymized insurance claims data were used from a                     
commercially insured, low-risk population across several U.S. states and combined with                     
inferred sociodemographic data and data derived from the patient-held mobile application                     
itself. Our approach involves the creation of two models and the comparative analysis of                           
the methodologies and performances therein. We first train a cost prediction model to                         
calculate the differences in predicted (without intervention) versus actual (with onboarding                     
onto digital health platform) healthcare expenditure for patients (​N = ​1,242). This enables                         
the classification of impactability if differences in predicted versus actual costs meet a                         
predetermined threshold. A random forest machine learning model was then trained to                       
accurately categorize new patients as impactable versus not impactable, reaching an                     
overall accuracy of 71.9%. We then modify these parameters through grid search to define                           
the parameters that deliver optimal performance. This demonstrates the potential to                     
successfully target, based on impactability, lower risk members in the payor population                       
with a digital health intervention. However, in the context of low-cost digital health                         
interventions, wide inclusion is possible. Instead, an impactability-based machine learning                   
model, such as the one described here, is able to maximise efficient spending of                           
non-operational costs e.g. patient recruitment. A roadmap is proposed to iteratively                     
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improve the performance of the model. As the number of newly onboarded patients and                           
length of use continues to increase, the accuracy of predicting impactability will improve                         
commensurately as more advanced machine learning techniques such as deep learning                     
become relevant. This approach is generalizable to analyzing the impactability of any                       
intervention and is a key component of realising closed loop feedback systems for                         
continuous improvement in healthcare.   
 
Introduction 
Efficient use of resources is a priority for healthcare systems worldwide. An ageing,                         
multimorbid population is demanding more health services, placing pressure on systems                     
already struggling with and a lack of interconnectivity between providers, low productivity,                       
poor adaptability​1 and lack of patient engagement. Care management programs can                     
ameliorate some of these pressures by enabling effective coordination of care towards                       
preventing avoidable need for healthcare utilization.​2 
 
Previous studies of care management interventions assert that savings can only be                       
achieved by targeting those with the highest number of chronic diseases, who also have                           
the highest healthcare costs.​3,4 However, selectively targeting interventions to high-cost,                   
high-need (HCHN) patients assumes that those with the highest health expenditures are                       
reservoirs of untapped savings. Across a broad variety of chronic care management                       
programs remunerated by Medicaid targeting HCHN patients, the anticipated savings have                     
fallen short. On average, across 34 programs, there was no effect on hospital admissions                           
or regular Medicare expenditures.​5  
 
The concept of impactability reframes how to allocate healthcare resources by matching                       
individuals to interventions based on their ability to benefit from these. ‘Benefit’ in the                           
analysis laid out here is most easily measured by identifying a reduction in healthcare                           
costs (in $US), which acts as a proxy for improvements in health outcomes.​7 However,                           
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attainments other than cost-saving, such as clinical outcomes or patient reported                     
outcome measures (PROMS), can also be applied to a measure of impactability. As a                           
relatively new approach to resource allocation, work by DuBard and Jackson generated an                         
‘impactability score’ that uses administrative data to predict achievable savings in a care                         
management population in North Carolina.​8 Aligning with the principles of impactability,                     
Hawkins et al developed a propensity-to-succeed (PTS) score to prioritize individuals most                       
likely to benefit from a care coordination intervention.​9 Put simply, impactability reframes                       
how to allocate healthcare interventions by identifying patients to target for the greatest                         
return on investment, thereby acknowledging the reality that patients with the highest                       
healthcare cost may not overlap with being the most impactable.  
 
The richness of the data collected by digital health management solutions makes these an                           
opportune tool for exploring impactability. Adoption of digital tools is increasing across                       
healthcare, ranging from wearable devices to mobile-enabled disease and care                   
management applications. One of the benefits of digital health solutions as opposed to in                           
person consultations is that they have the potential to drastically reduce the cost of care                             
delivery, meaning that care can be offered to more people if that care can be safely and                                 
successfully encapsulated in a digital health intervention. Digital health tools have added                       
policy relevance as they can help realise a paradigm shift from a fee-for-service to a                             
value-based care model, namely by offering improved patient outcomes with the added                       
virtue of being cost-effective.​6,10 Care management has been particularly successful in                     
implementing digital health tools.​11–13 However, in the face of increasingly restricted                     
budgets, whom to target with these interventions is a pertinent question for risk bearing                           
organisations. 
 
For care management, the relatively low start-up and maintenance cost of digital health                         
solutions already enables the inclusion of more members. It is also important to                         
acknowledge that digital health solutions clearly offer benefits to patients and providers                       
that go beyond cost-savings. In the context of digital care management at least,                         
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impactability-based allocation should not be the rationale for offsetting the cost of setup                         
and day-to-day upkeep of the technology. These interventions can, however, have                     
significant external costs, namely the marketing campaigns needed to recruit patients. In                       
the context of a widely available digital health care management tool, care management                         
teams can use an impactability-based approach to target marketing campaigns, thus                     
maximising recruitment of those patients most likely to benefit (and subsequently offset                       
the cost of marketing).  
 
It is through recent technological advances that refinement of an impactability based                       
approach has become possible. Most digital health tools share a vital strength: the ability                           
to collect data. Enabled by the combination of ever-larger datasets and increasing                       
computing power, machine learning (ML) methods are now able to effectively ‘learn’ from                         
these data, highlighting patterns and in many instances exhibiting judgement superior to                       
that of humans.​14 As a branch of artificial intelligence, ML methods transform the inputs of                             
an algorithm into outputs using statistical, data-driven rules that can be automatically                       
derived from a large set of examples. A number of successes include aiding diagnosis of                             
sight-threatening eye disease​15​, predicting risk of hospital readmission​16 and predicting                   
onset of type 2 diabetes.​17 Across other industries, ML techniques are being applied in                           
many sectors including law​18​, finance​19 and urban planning​20​. However, ML techniques                     
remain largely untested in the domain of impactability-based resource allocation, having                     
previously relied on more classical, less powerful prediction models.​8,9 This highlights an                       
exciting new frontier for judicious allocation of finite resources that aligns itself well with                           
the principles of value-based healthcare. 
 
This study demonstrates an example of how a combination of ML methods can be used to                               
identify the features of patients whose costs significantly declined once onboarded onto a                         
digital health intervention i.e. highlighting the features that constitute impactability. Such                     
an approach allows a subsequent ML algorithm to predict a new patient’s impactability,                         
thereby offering a tool to assist in decision-making around allocating the intervention. We                         
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used data from a commercially insured population, combining insurance claims,                   
sociodemographic and patient-generated data (from the use of the patient-held mobile                     
app at the core of the digital health intervention described below)​.  
 
The study population was onboarded onto a digital health tool created by the team at                             
Wellframe Inc, a Boston based digital health company. The Wellframe intervention                     
consists of a of a mobile-enabled care management platform, based around an app that                           
includes a customized, interactive, daily health checklist displayed to patients on their                       
smartphone or tablet. ​Responses and interactions from users are collected as actionable                       
day-to-day-health information. The app serves to provide a sustained and supportive portal                       
of communication between patients and their care teams. ​A built-in concierge service                       
helps patients pursue their health goals, get their benefits questions answered and                       
navigate the healthcare system — all through a single, direct channel of communication.                         
The population in this study was onboarded onto the Wellframe app as part of a health                               
coaching programme, both patients and clinical teams received training on how to use all                           
of its features.  
 
Data 
The majority of the data used came from individual health care claims from June 10, 2015                               
through May 26, 2018, with other variables created using national databases.​21 Unique                       
patient ID, the date of the visit, type of the visit (inpatient or outpatient), amount paid by the                                   
provider for the visit, patient gender (male or female), patient date of birth, patient zip                             
code, and diagnosis(es) were recorded for each claim. Age was calculated as the number                           
of years between the date of birth and December 31, 2018. Education level, employment                           
status, income and poverty status were inferred from the patient’s zip code. Education                         
level variables included the percent of individuals living in the same zip code as the patient                               
with an education level of less than high school, high school, some college, an associate’s                             
degree, a bachelor's degree, and a graduate degree. Employment status included the                       
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percent of individuals living in the same zip code as the patient who were in the labor force                                   
and employed, in the labor force and unemployed, and not in the labor force. Income level                               
included two variables: the total income and average income for all individuals living in the                             
same zip code as the patient. Poverty status was represented as the percent of individuals                             
living in the same zip code as the patient living below the 138% Federal Poverty Level. 
 
Developing the impactability model discussed in this paper required integration of                     
multi-modal data and use of this data for model training and testing. This was achieved                             
using the infrastructure shown in figure  1,​ ​ built using Google Cloud Platform (GCP).  
 
 
Figure 1. ​Airflow is a data orchestration service able to ingest client provided claims information and merge                                 
it with transactional data generated by the Wellframe platform. The amalgamation of these two data sets                               
was stored into a centralized data warehouse: BigQuery. As a serverless, managed data warehouse,                           
BigQuery allows the deployment of a centralized data warehousing solution without the need to maintain                             
large computing clusters. As a data footprint grows, this can reduce operational cost while giving data                               
scientists flexibility in how they interact with the collected data. Once in BigQuery​, ​a collaboration of data                                 
science teams is able to build models by leveraging Cloud datalab and Jupyter Notebooks. They can also                                 
access cutting edge tools like Keras, to build deep neural nets and train models using Cloud TPUs (Cloud                                   
Tensor Processing units). Once a model is trained, Cloud ML Engine can deploy it into production and make                                   
it available via an application programming interface (API). This API can then be utilized by applications                               
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(mobile apps or web apps) to predict a client’s propensity to benefit. All operational data generated from the                                   
interaction of users with the platform is stored in Cloud SQL database. This data is replicated at regular                                   
interval into a data warehouse. The fast availability of this data enables validation that the recommendations                               
offered by the deployed models are actually yielding the intended goals. The data collected can be exposed                                 
via Looker to enable business users to access the results of a predictive model​. ​Looker allows businesses to                                   
track key conversion metrics that can help assess the impact of the recommendations, without requiring                             
expertise in data.  
 
For each patient, claims were combined by month. The total cost for the month was the                               
sum of the amount paid for each claim that month. Any month a patient did not have a                                   
claim the total cost was set to 0 dollars. The rolling cost, the moving average cost of the                                   
last 6 months, was also calculated in an effort to smooth out short-term fluctuations and                             
highlight longer-term trends. Total number of inpatient visits per month were calculated                       
from the type of visit reported in the claim. The total number of unique diagnoses was                               
calculated from all claims in a given month.  
 
Finally, the data were split into pre (time before onboarding e.g. before accessing                         
Wellframe) and post (time since onboarding) time periods. The pre time period included                         
monthly data for all visits before onboarding to Wellframe. The post period included                         
monthly data for all visits after onboarding to Wellframe. The month a patient onboarded                           
was designated as ​T = 0, and the range of values in this data set were ​T = [-35, 21]. Only                                         
patients who had onboarded were used in the analysis, resulting in a sample size of N =                                 
1,280. 
 
Methods 
With the overarching goal of predicting which patients would benefit the most from                         
onboarding, our targeting process includes building two different types of models: a cost                         
prediction model and an impactability prediction model. The cost prediction model is used                         
to predict the monthly cost after time ​T = 0 for patients had they not onboarded. This can                                   
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be thought of as estimating the counterfactual cost for these patients who did onboard.                           
After predicting these counterfactual costs, the difference in actual cost and predicted                       
cost is calculated for each patient, an impactable threshold is chosen, patients are labeled                           
as impactable or not, and the impactability model is used to classify patients as                           
impactable or not.  
 
Since the impactability prediction model depends on predictions made from the cost                       
prediction model, the cost prediction model must be built first. We included all individuals                           
who had at least 12 months of claims before onboarding, i.e. only those with a minimum ​T                                 
<= -12. This cutoff was chosen for two reasons. The first being only a small proportion of                                 
patients had claims information from more than 12 months before onboarding. The                       
second reason was to ensure enough prior information was available for each patient to                           
predict future monthly costs. This slightly decreased the sample size to N = 1,242. See                             
Table 1 for sample descriptive statistics. We then fit several models to predict the rolling                             
cost and the natural log of the rolling cost for months ​T = -2 and ​T = -1 using months ​T =                                           
-12 to ​T = -3. We used only the months before onboarding to fit our cost prediction models                                   
since our goal is to estimate monthly cost had someone not onboarded. Due to the                             
longitudinal nature of our data, we fit different mixed effects models to account for the                             
repeated measures for each individual. For each type of outcome, rolling total and log                           
rolling total, we fit four models: a random intercept model with time as the only predictor, a                                 
random intercept model with all covariates described above as predictors, a random                       
intercept and random slope model with time as the only predictor, and a random intercept                             
and random slope model with all predictors. This resulted in a total of eight models. To                               
judge which model performed the best, we fit each model, predicted the cost for months ​T                               
= -2 and ​T = -1 for each patient, and then calculated the root mean square error (RMSE)                                   
and mean absolute deviation (MAD) between predicted cost and actual cost.  
 
Once the best cost prediction model was defined, cost for months ​T = 0, 1 and 2 were                                   
predicted using all months before onboarding for each patient. These predictions are used                         
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as an estimate of what the costs would have been had the patient not onboarded. The                               
average residual between the predicted and actual cost for the three months was                         
calculated for each patient and patients were then sorted by their residual value. Larger                           
negative residuals indicate predicted costs were higher than actual costs and larger                       
positive residuals indicate predicted costs were lower than actual costs. Patients were                       
then labeled as “impactable” if their residual was below a certain threshold, ​h​, ​and labeled                             
as not impactable if their residual was above this threshold.  
 
We then split the data into training (80%, n = 993) and testing (20%, n = 249) sets. Due to                                       
the relatively low sample size we did not use a validation set for this model building step.                                 
We then fit several random forest (RF) and logistic regression (LR) models to predict if a                               
patient is impactable or not using their gender, age, total cost for all claims before                             
onboarding, total number of inpatient visits before onboarding, total number of unique                       
diagnoses before onboarding, and all zip code level variables. For both RF and LR methods                             
we fit three different models; one that did not correct for class imbalance, one that                             
corrected for class imbalance through weighting,​22 and one that corrected for class                       
imbalance through the synthetic minority over-sampling technique (SMOTE).​23 The                 
performance of each model was measured by the number of false positives and false                           
negatives for different thresholds of the impactable threshold, ​h, ranging from the 10th                         
percentile to the 90th percentile. In addition to the threshold ​h​, a classification threshold ​c                             
was allowed to vary between 0.5 and 0.9. When ​c = 0.5, a patient is classified as not                                   
impactable if the predicted probability of that patient not being impactable is above 50%.                           
As ​c increases, the model must be more certain a patient is not impactable before                             
classifying them as not impactable.  
 
 
Results 
The best cost prediction model was deemed the model with the smallest RMSE and MAD.                             
For this data set, this was the random intercept and random slope model with time trend                               
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as the only predictor for rolling cost. This model produced an RMSE equal to 1340.49 and                               
MAD equal to 93.80. This cost prediction model produced residuals ranging from -$462                         
(10th percentile) to $382 (90th percentile) for this population.  
 
The number of false negatives for each RF and LR model and every value of ​h and ​c are                                     
presented in Figures 2-7. The threshold ​h in terms of percentile of patients as well as the                                 
dollar amount equivalent are presented on the x-axis. The random forest models, models                         
1, 2 and 3, show monotonic curves that are fairly smooth. As the impactability threshold ​h                               
increases, the number of false negatives increases for these models. This is not                         
surprising; as ​h increases, the number of individuals labeled as impactable increases and                         
thus the number of possibilities in classifying an impactable patient as not impactable                         
also increases. Inversely, as the classification threshold ​c increases, the number of false                         
negatives decreases. This is also intuitive: as the threshold for classifying an individual as                           
not impactable increases, our model must be more confident in it’s classification. As a                           
result, more patients will be classified as impactable, resulting in fewer false negatives.  
 
The feature importance values were also recorded for each impactable threshold ​h for                         
models 1, 2 and 3 to gain insight into which variables were most predictive of                             
impactability. For all three models, across all thresholds, the number of inpatient visits in                           
the pre-period, the total cost in the pre-period, a patient’s age, and the number of                             
conditions diagnosed in the pre-period were the most predictive of impactability.                     
Interestingly, the feature importance of gender was higher for values of ​h that indicate a                             
higher class imbalance. Specifically, gender was more predictive of impactability for low                       
and high values of ​h​, but lower for middle values of ​h​, around 0.5. This pattern was                                 
inverted for all other variables with low predictive power.  
 
The logistic regression models, models 4, 5 and 6, are not monotonic and much less                             
smooth compared to the random forest models. For some combinations of ​h ​and ​c the                             
number of false negatives plummets to 0 or spikes to a maximum point. A value of 0 or                                   
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close to 0 indicates the model is classifying every patient, or nearly every patient, as                             
impactable. This results in all impactable patients receiving care and no false negatives. A                           
value near the maximum number possible given ​h ​and ​c indicates the model is classifying                             
everyone, or nearly everyone, as not impactable. In this case all or nearly all impactable                             
individuals do not receive care and the number of false negatives increases dramatically. 
 
Varying the thresholds ​h ​and ​c highlight the tradeoff in the number of FPs and FNs. While                                 
it is true that deciding to target all patients for on-boarding would eliminate the number of                               
FNs, this may not be feasible for the resources at hand. Depending on the size of the                                 
population and resources needed, recruitment costs and effort could be prohibitive and                       
more of a balance in the number of FNs and FPs may be more realistic. With this in mind,                                     
the thresholds that result in the best tradeoff for each model, with corresponding                         
sensitivity, specificity, number of false positives and false negatives, and total number of                         
misclassified patients are presented in Table 2. All three RF models limit FPs more than                             
FNs while all LR models limit FNs more than FPs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DRAFT MANUSCRIPT 
 
 
 
 
 
Measured Variables  Sample, N = 1,242 
Gender, n (%) 
     Female 
     Male 
 
 
864 (69.6) 
378 (30.4) 
Age, M (SD) 
 
44.8 (11.1) 
Inferred Variables   
Education level percent, Med (IQR) 
     <9th grade 
     9-12th grade 
     High school diploma 
     Some college 
     Associates degree 
     Bachelor’s degree 
     Graduate degree 
 
 
  2.2 (3.1) 
  4.1 (3.4) 
26.0 (12.4) 
23.4 (5.2) 
  9.6 (3.4) 
21.1 (13.6) 
  9.5 (9.4) 
Average income, Med (IQR) 
 
$59,780 ($24,660) 
Percent insured, Med (IQR) 
 
92.2 (6.0) 
In labor force, Med (IQR) 
     Percent employed 
     Percent unemployed 
 
 
69.5 (8.5) 
2.4 (1.7) 
Percent not in labor force, M (SD) 
 
27.8 (7.4) 
Percent below poverty line, Med (IQR) 
 
15.5 (7.2) 
Number of inpatient visits in pre period, Med (IQR) 
 
8 (28) 
Number of diagnoses in pre period, Med (IQR) 
 
14 (13) 
Total cost in pre period, Med (IQR) 
 
$2,872.80 
($9,365.70) 
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Table 1. Measured and Inferred Sample characteristics. 
 
Figure 2. Number of false negatives as a function of impactable threshold ​h​ and classification threshold ​c 
for model 1; Random forest without correction for class imbalance. The integers on the x-axis represent the 
residual dollar amount threshold for labeling a patient as impactable. The decimals in parentheses on the 
x-axis represent the percentile of the patients in the test set that were labeled as impactable. 
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Figure 3. Number of false negatives as a function of impactable threshold ​h​ and classification threshold ​c 
for model 2; Random forest with correction for class imbalance using weighting. 
 
Figure 4. Number of false negatives as a function of impactable threshold ​h​ and classification threshold ​c 
for model 3; Random forest  with correction for class imbalance using SMOTE. 
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Figure 5. Number of false negatives as a function of impactable threshold ​h​ and classification threshold ​c 
for model 4; Logistic regression without  correction for class imbalance. 
 
Figure 6. Number of false negatives as a function of impactable threshold ​h​ and classification threshold ​c 
for model 5; Logistic regression with correction for class imbalance using weighting. 
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Figure 7. Number of false negatives as a function of impactable threshold ​h​ and classification threshold ​c 
for model 6; Logistic regression with correction for class imbalance using SMOTE. 
 
Model  Impactable 
threshold ​h 
Classification 
threshold ​c 
Sensitivity  Specificity  FP  FN  Total 
misclassified 
1  -$22 (0.6)  0.5  0.39  0.72  30  89  119 
2  -$22 (0.6)  0.65  0.63  0.47  55  54  109 
3  -$22 (0.6)  0.5  0.37  0.71  30  89  119 
4  $8 (0.7)  0.55  0.96  0.11  62  8  70 
5  -$28 (0.55)  0.6  0.97  0.08  102  4  106 
6  $8 (0.7)  0.55  0.96  0.11  62  8  70 
Table 2. Best performance thresholds and outcomes for each model. 
 
Discussion 
This study demonstrates the potential of an impactability-based framework for resource                     
allocation, one that has been enabled by harnessing the combined power of digital health,                           
machine learning models and large datasets. We took an approach that first predicted                         
future costs without a digital health intervention and compared predicted and observed                       
costs. An impactable population was defined where these two figures deviated. Next, a                         
further machine learning model was trained on data from the impactable population to                         
subsequently be able to accurately predict a patient’s ability to benefit (incur lower                         
healthcare costs) if onboarded onto the digital health solution. Grid search was then                         
performed to identify the optimal thresholds for impactability and confidence in prediction                       
thereof. Far from being a definitive methodology, this study sought to demonstrate the                         
utility of measuring impactability and advance a general framework for doing so with a                           
roadmap for how both methodology and performance could be improved.   
 
Current ‘risk score’ approaches assume every patient is potentially impactable and                     
therefore fail to take into account the many factors that can contribute to a patient’s                             
DRAFT MANUSCRIPT 
 
 
likelihood of being affected by care.​24 Previous work by DuBard and Jackson​25 found only a                             
53% overlap between the patients with the highest impactability scores and those with the                           
highest risk of inpatient admission, concluding in this instance that traditional risk-based                       
methods are missing vital cost saving opportunities. Impactability is agnostic to which                       
patients are most at risk of a certain outcome; the work described here defines it as                               
attaining a threshold of cost saving as a consequence of onboarding onto a digital health                             
intervention. Furthermore, a risk score (primarily derived from an amalgam of different                       
parts of a patient’s disease profile) is invalidated by virtue of not being modifiable by a                               
patient’s potential impactability with a given intervention.  
 
Going against the convention of targeting those who currently have high cost or utilization                           
-- or those with the highest predicted risk thereof -- justifiably raises the question of                             
fairness and concerns around algorithmic bias, a particular concern with machine learning                       
models.​25 However, the startup and running costs of the digital health tools at the core of                               
this study is low, and therefore wide, inclusive rollout is made possible. T​he quantity of                             
saving at an individual level (at times in the tens of dollars) can appear low, but the sum of                                     
potential savings is considerable when considering the much lower cost of the digital                         
health intervention and the large populations of patients onboarded. ​It is within the                         
significant non-operational budgets, such as marketing, where impactability can offer a                     
targeted approach that channels resources towards recruiting those most likely to achieve                       
the reduced costs offered by the intervention. For non-digital health interventions this                       
framework can be used to determine how to best allocate care resources in general.  
 
Both the impactable and non-impactable population in this study are smartphone users. It                         
has been suspected that smartphone use is a proxy for other propitious social ​factors                           
however it is plausible that as smartphones near ubiquity this ‘digital divide’ will narrow                           
and this association will weaken.​26 In sum, the generalisability of this impactability model                         
to populations of non-smartphone users is not clear. The methodology can be used to                           
examine the impactability of non-digital healthcare interventions and this is the subject of                         
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further investigation by the research team at Wellframe. Further work is in progress by a                             
research group in North Carolina that leverages an impactability score for allocation of                         
pregnancy care management by identifying those patients at-risk of low-weight births                     
whose characteristics match those who have previously benefited from additional care.​27 
 
As frameworks centered around impactability mature and access and use of digital health                         
platforms increases, a new opportunity will be enabled: creating a closed-loop feedback                       
system that lends real-time insights into a patient’s ability to benefit from an intervention.                           
This allows not only propitious selection but per-patient customisation, moving away from                       
one-size-fits all care models in favour of data-driven individualised and responsive care. 
 
While promising for use in future intervention targeting, this work does have limitations.                         
Perhaps the biggest hindrance to model performance is the relatively small sample size                         
due to the fact that the data was collected from an initial rollout phase of the digital health                                   
solution in question. The sample size constraint resulted in small training and test sets,                           
and prohibited the creation and use of a validation set. As more patients onboard, more                             
data will be available to train both the cost prediction model and the impactability model                             
and a validation set will be used, resulting in better predictions of cost and impactability                             
status. Our models also suffer from aggregated demographic variables since the only                       
demographic variable in the dataset was 5 digit zip code. Knowing a patient’s individual                           
education level, income, employment status, and poverty status would result in more                       
accurate predictions. Moreover, other demographic variables such as number of                   
individuals in a patient’s household and race would add to the predictive power of the                             
models. The zip code level variables we use act as proxies for individual demographics are                             
less reliable and more imprecise. Another limitation is the amount of follow-up time for                           
each individual. Most patients in this population had approximately 12 months of claims                         
prior to onboarding. Having more historical data may elucidate temporal patterns in care                         
and improve future cost prediction and impactability classification. A matched control                     
group from the same population was not used for comparison due to strong selection bias                             
DRAFT MANUSCRIPT 
 
 
for patients who used the digital health intervention. Patients who were recruited and                         
chose to participate saw a markedly different cost pattern in the months immediately prior                           
to those who were recruited but chose not to participate. This fundamental difference in                           
populations was not able to be controlled for by propensity score matching. This analysis                           
is currently limited to one payer’s commercially insured population. To establish the                       
external validity of this model it will be tested on other payer’s populations and ultimately                             
across payer’s. Additional data from other payers is likely to improve generalisability and                         
increase model performance. It may also highlight differences in patient populations that                       
may be beneficial to prediction and classification.  
 
Conclusion 
With Digital Health technologies, health plans have the opportunity to deliver preventative                       
interventions against incipient chronic disease that encompass more than just the highest                       
risk populations. Machine learning models’ definition of impactability assists in effective                     
spending on marketing these interventions to patients. Though the concept of assigning                       
impactability scores may seem like an endpoint, such predictive analytics are only set to                           
improve, offering continually iterating insights that are responsive to change and help                       
tailor interventions that enable cost-effective use of valuable resources. Digital Health has                       
reduced the cost of care delivery such that much larger populations can be served in a                               
cost effective manner hitherto impossible with a visit or telephone based care model. With                           
analysis of impactability as described in this paper, it is possible to create a closed loop                               
feedback system for continuous improvement in healthcare where informed patient                   
selection is married with digital health interventions dynamically adapted to minimize the                       
delta between observed and expected benefit, with the data generated used to further                         
improve patient targeting. This work is a proposal for a general approach to patient                           
targeting based on impactability instantiated in a specific model with a roadmap to                         
improve model performance and generalizability.  
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